Bio-Path at-a-Glance ; NASDAQ: BPTH ; Focus: Drug delivery for nucleic acid drugs ; Shares Outstanding: 617,633 ; Cash (at 12/31/23):, $1.1 million ; Burn rate: $1.0 ...
Investors · Overview · SEC Filings · Corporate Governance · Media · Press Releases · Events · Presentations & Publications · Careers · Contact Us. A new path in ...
Get the latest insights on Bio-Path Holdings, Inc. Common Stock (BPTH) with press releases and corporate news to help you in your trading and investing ...
Mar 10, 2024 · Welcome to the Bio-Path Holdings Conference Call and webcast to review the company's full year 2023 financial results and to provide an update ...
Find the latest SEC Filings data for Bio-Path Holdings, Inc. Common Stock (BPTH) including 10-K and 10-Q forms at Nasdaq.com.
Get Bio Path Holdings Inc (BPTH.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Nov 20, 2023 · Welcome to the Bio-Path Holdings conference call and webcast to review the company's third quarter 2023 financial results and to provide an ...
Bio-Path Holdings (BPTH) Earnings Dates & Reports - TipRanks.com
www.tipranks.com › stocks › earnings
Rating
(975)
Bio-Path Holdings (BPTH) will release its next earnings report on May 15, 2024 ... investors and does not represent returns that any investor actually attained.
Missing: relations | Show results with:relations
Get Bio Path Holdings Inc (BPTH.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia ...
Missing: relations | Show results with:relations